Skip to main content
. 2006 Oct 21;12(39):6331–6338. doi: 10.3748/wjg.v12.i39.6331

Figure 3.

Figure 3

Actuarial survival curves for distal spleno-renal shunt (DSRS) and endoscopic sclerotherapy (ES). DSRS vs ES for the first 5 years (breslow test P = 0.038) while no differences were found in the final outcome (log rank test P = 0.1168)